NETSOL Technologies Reports 14% Revenue Growth and EPS of $0.03 in Fiscal Third Quarter 2024
14% increase in Total Revenues to $15.5 million in 3Q ‘24 60% increase in 3Q ‘24 Services Revenues to $7.8 […]
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader […]
Gray Television Commences Cash Tender Offer for Its 5.875% Senior Notes Due 2026
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray,” the “Company,” “we,” or “our”) (NYSE: GTN) announced today […]
Gray Announces Private Offering of Senior Secured Notes
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray,” “we,” “us” or “our”) (NYSE: GTN) announced today that […]
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
SNK01, a cryopreserved, autologous enhanced natural killer cell therapy, delivered in highest dose to date, demonstrates preliminary clinical benefit without […]
Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
BELGRADE, Mont., May 20, 2024 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: […]
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
Mainz Biomed Presented Industry Leading Results: 97% Sensitivity for Colorectal Cancer, 82% for Advanced Precancerous Lesions The eAArly DETECT results […]
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
SAN JOSE, Calif., May 20, 2024 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today that it will participate in the […]
Infinera Names Regan MacPherson Chief Legal Officer and Corporate Secretary
SAN JOSE, Calif., May 20, 2024 (GLOBE NEWSWIRE) — Infinera (Nasdaq: INFN) announced today that Regan MacPherson has been named […]
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
SAN DIEGO, May 20, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic […]
